Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases
about
Mahogunin ring finger-1 (MGRN1) E3 ubiquitin ligase inhibits signaling from melanocortin receptor by competition with GalphasMetabolic rewiring in melanomaMolecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic targetMolecular aspects of melanocytic dysplastic neviA systems biology analysis of metastatic melanoma using in-depth three-dimensional protein profiling.Biomarkers in melanoma: predisposition, screening and diagnosis.Oncogenes in melanoma.UV-induced skin cancer: similarities--variations.A strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapy.NF-kappaB activation in melanoma.Broad targeting of resistance to apoptosis in cancer.Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies.Epigenetic events in malignant melanoma.A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cellsGenetics of uveal melanoma and cutaneous melanoma: two of a kind?Resistance to transforming growth factor β-mediated tumor suppression in melanoma: are multiple mechanisms in place?The melanoma revolution: from UV carcinogenesis to a new era in therapeutics.Malignant Melanoma of the Nail Apparatus: A Fluorescence In Situ Hybridization Analysis of 7 Cases.Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization.Genetics of melanoma progression: the rise and fall of cell senescence.Melanocytic nevi and melanoma: unraveling a complex relationship.C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells.Discovery of potential biomarkers in human melanoma cells with different metastatic potential by metabolic and lipidomic profiling.Distribution of the c-MYC gene product in colorectal neoplasia.Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response.UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas.Inhibition of c-Myc oncoprotein limits the growth of human melanoma cells by inducing cellular crisis.Extra copies of c-myc are more pronounced in nodular melanomas than in superficial spreading melanomas as revealed by fluorescence in situ hybridisation.HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma.Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications.AMPK promotes survival of c-Myc-positive melanoma cells by suppressing oxidative stress.Ligand-activated BMP signaling inhibits cell differentiation and death to promote melanoma.C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling.A geometric approach to characterize the functional identity of single cells.MYC gene amplification is a rare event in atypical fibroxanthoma and pleomorphic dermal sarcoma.
P2860
Q24314383-087C782C-E513-4BB7-B363-6B72DEFE5238Q28069081-4B74F348-3540-4443-8367-4E223C625D51Q34438536-1A55D002-65A8-4943-8558-20F91C4FE6B0Q34622005-8043A2A8-C854-4909-ABC6-2E88E67701E0Q34762291-542D8968-A940-46DC-8D01-F9EE8D7EA96EQ35089153-451A58C9-9AFF-4FA0-950D-3F20449C9B7EQ35146560-34A7E593-FB81-416F-BA04-A4FB084557BFQ36168638-4A989839-5C39-42D8-8B11-B6BCC42A4BBBQ36335331-C3742A76-A3FF-4302-A881-721DA1AE8117Q36416479-FBFC4F2A-D960-4BF5-BD3B-332EC9DDDA8DQ36483749-B9783877-11BE-455A-B236-3BC9E7A513B5Q36707344-564112CB-EE9E-4CE8-B8A7-C3708A1A3BBFQ36764224-F73E070C-0C6A-46B7-BC63-C1A1FB4F69E8Q36973832-C33D6E97-5739-43D2-B631-80D464DFEE58Q37772777-4E38A17E-D94C-404A-BC2E-5796BF9B17F3Q37775417-819557E7-C24A-4047-9459-9E0076FEFF03Q38270141-681C064B-3965-4C49-8CF3-B8E18D0B34B3Q38380317-D3CE6926-90BC-4483-BABA-45348A184440Q38492340-AB59DB13-720F-4947-B370-92FAA18AC74DQ38589518-1C581D25-9FF7-474F-AE04-3BDFCFDFF601Q38730348-81777171-63FE-4D80-AA73-00EA65A5E30CQ39954044-7825DC3A-7C85-4602-9EEC-40F06264B06BQ41458701-D77A0A10-9F26-4EF8-8F3D-9AEEB7BC5145Q41850038-B7DEFF20-2296-400C-848A-4B7C71206B74Q42038580-CEFA627D-CA6D-4CDE-AB15-AC7548B107C3Q43981132-6AD9E3EA-5367-4385-AA71-1DA67ABF2523Q44489695-1E6DED2E-1B7F-4F4E-B372-1BFD7DB82523Q47279137-ADADDB9D-9DE9-4E0A-9E74-E90D6BB72148Q47325071-D07D750B-694A-4E0E-91ED-AA2CC223A7CAQ47759599-4CC7BEAC-5C9E-4589-84E5-3098DB8F9A67Q50027280-0D503640-5806-4A51-80F2-FA358865E055Q50088009-7E4A5746-02CE-4271-8C2E-D817BDBEF128Q51560902-F275C83D-B856-4476-89DE-1221B0A7E54FQ52582070-DBE82EEE-B50D-4E83-A7D5-90782BE0074EQ55382894-1DD87BD1-5546-4807-9E73-18ADD7C62F37
P2860
Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Extra c-myc oncogene copies in ...... lanoma and melanoma metastases
@ast
Extra c-myc oncogene copies in ...... lanoma and melanoma metastases
@en
Extra c-myc oncogene copies in ...... lanoma and melanoma metastases
@nl
type
label
Extra c-myc oncogene copies in ...... lanoma and melanoma metastases
@ast
Extra c-myc oncogene copies in ...... lanoma and melanoma metastases
@en
Extra c-myc oncogene copies in ...... lanoma and melanoma metastases
@nl
prefLabel
Extra c-myc oncogene copies in ...... lanoma and melanoma metastases
@ast
Extra c-myc oncogene copies in ...... lanoma and melanoma metastases
@en
Extra c-myc oncogene copies in ...... lanoma and melanoma metastases
@nl
P2093
P2860
P3181
P356
P1476
Extra c-myc oncogene copies in ...... lanoma and melanoma metastases
@en
P2093
G M Kraehn
K M Greulich
P2860
P2888
P3181
P356
10.1054/BJOC.2000.1535
P407
P577
2001-01-05T00:00:00Z
P5875
P6179
1004973713